주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

Elsevier
엘스비어와 함께 출판
Press release

Three US regions hit the hardest by deaths of despair since 2010

Ann Arbor | 2023년 4월 26일

Co-occurring clusters of suicide, overdose, and liver disease mortalities identified in the US west, southeast, and Appalachia/rust belt, report investigators in the American Journal of Preventive Medicine

new studyopens in new tab/window in the American Journal of Preventive Medicineopens in new tab/window, published by Elsevier, identified three overlapping clusters of deaths of despair (i.e., suicide, overdose, and chronic liver disease and cirrhosis deaths) across the United States since 2010. Noting the sharp increase in deaths of despair documented in recent years, the investigators analyzed mortality data for individuals 10 years of age or older from 2000-2019 to detect geographic and temporal patterns. The findings showed six suicide clusters, four overdose clusters, nine alcohol-related liver disease clusters, which coincided in three large areas of the US west, southeast, and Appalachia/rust belt.

“Knowledge of geographic areas where suicide, overdose, and liver disease deaths are higher than expected, and where they coincide over multiple years, can help identify persistent clusters of deaths of despair that warrant public health intervention and continued or enhanced surveillance. Understanding which communities are at risk for co-occurring deaths of despair can assist public health entities to advocate for resources and funding to address the burden of mortality,” explained lead investigator Danielle L. Steelesmith, PhD, Center for Suicide Prevention and Research, The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH, USA.

Overall, mortality rates in the US have been increasing since hitting an all-time low in 2014. Life expectancy stopped trending upward in this period. These developments correspond with the surge in deaths of despair, which increased from 22.7 to 45.8 per 100,000 persons from 2000 to 2017. Overdoses increased the most, but suicides and liver deaths were also on the rise.

Little research has examined how the different categories of deaths of despair map out geographically and within specific timeframes. This project is the first to employ the relatively new and innovative methodology of co-occurring clusters to better understand how the different components interact and cluster together. The clusters identified for each type of death align with the times and places noted in prior research. When the specific clusters were mapped out together, three large intersecting areas stood out, in the west (counties in Wyoming, Montana, Colorado, Idaho, Utah, and New Mexico), southeast (counties in Florida, Georgia, South Carolina, North Carolina, Mississippi, Alabama, Louisiana, Tennessee, Kentucky, and Illinois) and throughout Appalachia/rust belt regions (counties in West Virginia, Virginia, Ohio, Indiana, Michigan, Delaware, Maryland, Pennsylvania, and western New York).

Caption: County relative risk and geographic location of space-time co-occurring clusters of deaths of despair in the United States, 2000-2019 (Credit: American Journal of Preventive Medicine).

“Our findings highlight specific regions and counties at increased risk for these deaths that can be analyzed further to improve our understanding of why deaths of despair have been increasing. In addition, we identified certain areas of concern outside of the co-occurring clusters, such as growing suicide rates in Maine, New Hampshire, and Vermont, an excess of liver disease deaths in Rhode Island, and alarming number of overdoses in eastern Oklahoma. These regions would benefit from more targeted interventions and prevention efforts,” added Dr. Steelesmith.

---

Notes for editors

The article is“Spatiotemporal Patterns of Deaths of Despair across the U.S., 2000 to 2019,” by Danielle L. Steelesmith, PhD, Megan R. Lindstrom, PhD, Huyen T.K. Le, PhD, Elisabeth D. Root, PhD, John V. Campo, MD, and Cynthia A. Fontanella, PhD (https://doi.org/10.1016/j.amepre.2023.02.020opens in new tab/window). It appears online in advance of the American Journal of Preventive Medicine, volume 65, issue 2 (August 2023), published by Elsevier.

The article is openly available for 30 days at https://www.ajpmonline.org/article/S0749-3797(23)00093-4/fulltextopens in new tab/window.

Full text of this article is also available to credentialed journalists upon request; contact Jillian B. Morgan at +1 734 936 1590 or [email protected]opens in new tab/window. Journalists wishing to interview the authors should contact +1 614 355 0495 or [email protected]opens in new tab/window.

About the American Journal of Preventive Medicine

The American Journal of Preventive Medicineopens in new tab/window is the official journal of the American College of Preventive Medicineopens in new tab/window and the Association for Prevention Teaching and Researchopens in new tab/window. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. The journal features papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and alcohol and drug abuse. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. The journal also publishes official policy statements from the two co-sponsoring organizations, health services research pertinent to prevention and public health, review articles, media reviews, and editorials. www.ajpmonline.orgopens in new tab/window

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.

연락처

JBM

Jillian B. Morgan

MPH, Managing Editor AJPM

+1 734 936 1590

Jillian B. Morgan 이메일